与年龄相关的黄斑退化中的地理缩的基因疗法:当前的见解
Muhammad Usman Jamil1, Nadia K Waheed2
1New England Eye Center, Tufts Medical Center, Boston, MA, 02116, USA.
Eye (London, England)
|November 23, 2024
概括
地理缩 (GA),是一种晚期的黄斑变性,涉及视网膜病变. 补充抑制和基因疗法为减缓GA进展提供了新的希望.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 地理缩 (GA) 是干燥的与年龄有关的黄斑变性晚期,以视网膜病变为特征.
- 补充系统的过度激活对GA的发展和进展作出了重大贡献.
- 最近FDA批准的疗法为管理GA提供了新的希望.
研究的目的:
- 提供地理缩 (GA) 的全面概述.
- 讨论GA的风险因素,患病率,病理生理学和遗传关联.
- 突出目前的GA治疗方法,专注于基因治疗干预措施.
主要方法:
- 地理缩 (GA) 的文献综述.
- 分析补充系统在 GA 中的作用.
- 检查基因疗法作为GA的新型治疗方法.
主要成果:
- 补体系统在GA的发病过程中起着至关重要的作用.
- 新兴疗法,包括基因疗法,显示出停止GA进展的希望.
- 基因疗法旨在利用眼睛作为"生物工厂"来生产治疗性蛋白质.
结论:
- 补充抑制是地理缩 (GA) 的有希望的治疗策略.
- 基因疗法代表了一种新的方法来解决GA在它的遗传来源.
- 对基因治疗的进一步研究有可能阻止GA的进展.
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.0K
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.1K
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
